Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens.
作者信息
Jabbarzadeh Kaboli Parham, Proestos Charalampos
机构信息
Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland.
Laboratory of Food Chemistry, Department of Chemistry, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Front Immunol. 2025 Feb 3;16:1560135. doi: 10.3389/fimmu.2025.1560135. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens.
Front Immunol. 2025 Feb 3;16:1560135. doi: 10.3389/fimmu.2025.1560135. eCollection 2025.
2
When glycobiology meets inflammasome activation: Insights and implications.
J Adv Res. 2025 Apr 5. doi: 10.1016/j.jare.2025.03.054.
3
The functional roles of protein glycosylation in human maternal-fetal crosstalk.
Hum Reprod Update. 2024 Jan 3;30(1):81-108. doi: 10.1093/humupd/dmad024.
4
N-glycan and Alzheimer's disease.
Biochim Biophys Acta Gen Subj. 2017 Oct;1861(10):2447-2454. doi: 10.1016/j.bbagen.2017.04.012. Epub 2017 Apr 29.
5
Recent Advances in Protein-Specific Glycan Imaging and Editing.
Chembiochem. 2023 May 2;24(9):e202200778. doi: 10.1002/cbic.202200778. Epub 2023 Apr 12.
6
Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
J Hematol Oncol. 2016 Sep 29;9(1):100. doi: 10.1186/s13045-016-0334-6.
7
Functions of Glycosylation and Related Web Resources for Its Prediction.
Methods Mol Biol. 2022;2499:135-144. doi: 10.1007/978-1-0716-2317-6_6.
8
Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research.
Sci Rep. 2024 Oct 4;14(1):23068. doi: 10.1038/s41598-024-73722-z.
9
Glycobiology of α-dystroglycan and muscular dystrophy.
J Biochem. 2015 Jan;157(1):1-12. doi: 10.1093/jb/mvu066. Epub 2014 Nov 7.
10
Databases and Bioinformatic Tools for Glycobiology and Glycoproteomics.
Int J Mol Sci. 2020 Sep 14;21(18):6727. doi: 10.3390/ijms21186727.
本文引用的文献
1
c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity.
Front Immunol. 2024 Nov 27;15:1498391. doi: 10.3389/fimmu.2024.1498391. eCollection 2024.
2
Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma.
Cancer Metastasis Rev. 2024 Sep;43(3):889-918. doi: 10.1007/s10555-024-10174-x. Epub 2024 Feb 27.
3
Aberrant protein glycosylation: Implications on diagnosis and Immunotherapy.
Biotechnol Adv. 2023 Sep;66:108149. doi: 10.1016/j.biotechadv.2023.108149. Epub 2023 Apr 6.
4
Glycosylation of Siglec15 promotes immunoescape and tumor growth.
Am J Cancer Res. 2021 May 15;11(5):2291-2302. eCollection 2021.
5
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.
Aging (Albany NY). 2020 Dec 8;12(23):23478-23496. doi: 10.18632/aging.202343.
6
Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells.
Sci Rep. 2017 Sep 8;7(1):11006. doi: 10.1038/s41598-017-11212-1.
7
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632.
Zotero 插件